ArticleMolecular pharmaceutics2025

Development of a Universal In Vivo Predictive Dissolution Method for a Borderline BCS III/IV Drug Guided by Modeling and Simulations─Acyclovir as a Case Study.

Mauricio A García et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.